SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-07-055759
Filing Date
2007-07-24
Accepted
2007-07-24 17:09:50
Documents
6
Period of Report
2007-07-24
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a07-20168_18k.htm 8-K 25804
2 EX-3.1 a07-20168_1ex3d1.htm EX-3.1 32107
3 EX-3.2 a07-20168_1ex3d2.htm EX-3.2 58718
4 EX-99.1 a07-20168_1ex99d1.htm EX-99.1 5740
5 GRAPHIC g201681mmi001.jpg GRAPHIC 2975
6 GRAPHIC g201681mmi002.gif GRAPHIC 73
  Complete submission text file 0001104659-07-055759.txt   128540
Mailing Address 125 CAMBRIDGEPARK DRIVE, 6TH FLOOR CAMBRIDGE MA 02140
Business Address 125 CAMBRIDGEPARK DRIVE, 6TH FLOOR CAMBRIDGE MA 02140 6174972070
AMAG PHARMACEUTICALS INC. (Filer) CIK: 0000792977 (see all company filings)

IRS No.: 042742593 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 000-14732 | Film No.: 07996829
SIC: 2835 In Vitro & In Vivo Diagnostic Substances